A phase II study of S-1 (14days-administrarion followed by 7days-rest ) for Metastatic Breast Cancer
Phase 2
- Conditions
- Breast Cancer
- Registration Number
- JPRN-UMIN000014096
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
(1)HER2 positive (IHC:3+ or FISH +) (2)History of non-breast malignancies within the 5 years prior to study entry (3)Symptomatic brain metastasis (4)Diffuse liver meta, or carcinomatous lymphangitis. (5)In addition, the case that a investigator judged to be inadequate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response Rate
- Secondary Outcome Measures
Name Time Method Disease control rate Progression-free survival Time to failure Adverse events